Showing 4,901 - 4,920 results of 60,573 for search '(( 50 ((a decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (nn decrease)) ))', query time: 0.83s Refine Results
  1. 4901
  2. 4902
  3. 4903
  4. 4904

    Influence of the Lactotripeptides Isoleucine–Proline–Proline and Valine–Proline–Proline on Systolic Blood Pressure in Japanese Subjects: A Systematic Review and Meta-Analysis of Ra... by Aurelie Chanson-Rolle (758940)

    Published 2015
    “…We performed a meta-analysis including all published studies to evaluate the SBP-lowering effect of IPP/VPP in Japanese subjects more comprehensively.…”
  5. 4905

    Zwitterion-Functionalized Cuprous Oxide Nanoparticles for Highly Specific and Enzymeless Electrochemical Creatinine Biosensing in Human Serum by R. K. Rakesh Kumar (14241205)

    Published 2023
    “…A linear response to creatinine concentration from 10 to 200 μM (<i>R</i><sup>2</sup> = 0.9876 and LOD = 5.0 μM) was observed, which covers the entire range of physiological creatinine in human serum. …”
  6. 4906
  7. 4907

    Data Sheet 1_Honeysuckle extracts as a potential inhibitor of SARS-CoV-2 infection.docx by Ping-Chang Lin (2848379)

    Published 2025
    “…We performed a cell viability assay, median tissue culture infection dose (TCID<sub>50</sub>) assay, and qRT‒PCR, and calculated the virus titers using the Reed-Muench method to evaluate the inhibitory effects of aqueous and alcohol HSEs on SARS‒CoV‒2 and explore the possible underlying mechanisms.…”
  8. 4908

    Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening by Shoya Yamada (1639105)

    Published 2019
    “…However, current screening methods for rexinoids are slow and require special apparatus or facilities. Here, we created 7-hydroxy-2-oxo-6-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-2<i>H</i>-chromene-3-carboxylic acid (<b>10</b>, CU-6PMN) as a new fluorescent RXR agonist and developed a screening system of rexinoids using <b>10</b>. …”
  9. 4909

    Self-Healable, Injectable Hydrogel with Enhanced Clotrimazole Solubilization as a Potential Therapeutic Platform for Gynecology by Monika Gosecka (1607017)

    Published 2022
    “…The degradation of the hydrogel constructed of the neat HbPGL was observed at approx. 40 °C, whereas the hydrogels constructed on HbPGL, where the monohydroxyl units were modified above 30 mol %, were stable above 50 °C. Moreover, the flow and self-healing ability of hydrogels were gradually decreased due to the reduced dynamics of macromolecules in the network as an effect of increased hydrophobicity. …”
  10. 4910

    Self-Healable, Injectable Hydrogel with Enhanced Clotrimazole Solubilization as a Potential Therapeutic Platform for Gynecology by Monika Gosecka (1607017)

    Published 2022
    “…The degradation of the hydrogel constructed of the neat HbPGL was observed at approx. 40 °C, whereas the hydrogels constructed on HbPGL, where the monohydroxyl units were modified above 30 mol %, were stable above 50 °C. Moreover, the flow and self-healing ability of hydrogels were gradually decreased due to the reduced dynamics of macromolecules in the network as an effect of increased hydrophobicity. …”
  11. 4911

    Self-Healable, Injectable Hydrogel with Enhanced Clotrimazole Solubilization as a Potential Therapeutic Platform for Gynecology by Monika Gosecka (1607017)

    Published 2022
    “…The degradation of the hydrogel constructed of the neat HbPGL was observed at approx. 40 °C, whereas the hydrogels constructed on HbPGL, where the monohydroxyl units were modified above 30 mol %, were stable above 50 °C. Moreover, the flow and self-healing ability of hydrogels were gradually decreased due to the reduced dynamics of macromolecules in the network as an effect of increased hydrophobicity. …”
  12. 4912
  13. 4913
  14. 4914
  15. 4915
  16. 4916

    HbA1c, lipid profiles and risk of incident type 2 Diabetes in United States Veterans by P. Jordan Davis (5746172)

    Published 2018
    “…Compared to normoglycemic Veterans (HbA1c: 5.05.6%; 31–38 mmol/mol), risks for diabetes were >2-fold in the moderate prediabetes risk group (HbA1c: 5.7–5.9%; 39–41 mmol/mol) (HR 2.37 [1.98–2.85]) and >5-fold in the high risk prediabetes group (HbA1c: 6.0–6.4%; 42–46 mmol/mol) (HR 5.59 [4.75–6.58]). …”
  17. 4917
  18. 4918
  19. 4919
  20. 4920